Zusammenfassung
Zunehmend werden mehrere „neuere“ Operationsmethoden oder Modifikationen bestehender Operationen, wie selektive Lasertrabekuloplastik, nicht-penetrierende Operationen, Wundheilungsmodulatoren etc. beim Glaukom angewendet. Es wird diskutiert, ob neuere Methoden auch besser sind, d. h., ob eine größere Anzahl von Patientinnen erfolgreich ohne weitere Medikation über einen längeren Zeitraum keine Progression des Krankheitsbildes zeigen. Messlatte bleibt nach wie vor die fistulierende Operation. Sie hat nach wie vor nicht ausgedient, im Gegenteil, durch exakte Technik lassen sich hervorragende Ergebnisse mit relativ dauerhafter tiefer Druckregulierung und reduziertem Risikoprofil erzielen. Nicht-penetrierende Operationen wie tiefe Sklerektomie oder Viskokanalostomie haben zwar ein deutlich niedrigeres frühpostoperatives Nebenwirkungsprofil, erreichen aber längerfristige Drucksenkungen zwischen 15 und 20 mm Hg meist nur mittels Zuhilfenahme augmentativer Maßnahmen. Die Argonlasertrabekuloplastik liefert ähnliche Ergebnisse wie die selektive Trabekuloplastik. Zyklodestruktive Eingriffe sollten auf Grund der ausgeprägten Nebenwirkungen nicht mehr mit Kryosonden, sondern mittels Laser durchgeführt werden. Implantate können den Augendruck bei therapierefraktären Glaukomen senken, man kämpft jedoch mit Hypotonien oder Abkapselungen der Platten. Einige innovative Techniken konnten sich zumindest in Zentren etablieren. Nach wie vor gibt es (noch) keine ideale Glaukomoperation.
Summary
More and more of “new” operations or modifications of operations are used in glaucoma surgery, e. g. the selective lasertrabeculoplasty, non-penetrating procedures or modulations of wound healing. The question is so far, if new procedures are better than the established ones, that means, if they are more successful in regulation of the intraocular pressure without medications over a longer period of time and will stop the progression of the disease. The benchmark is still the fistulating operation (trabeculectomy). A proper technique will lead to excellent results and will reduce the risk profile of side effects. Non-penetrating procedures like deep sclerectomy and viscocanalostomy do have indeed a lower short-time postoperative side effect profile, but a sufficient success can in most of the cases only be reached by additional measures like goniopuncture and implants. The argonlasertrabeculoplasty still has similar results in comparison to the selective trabeculoplasty. In cyclodestructive procedures a method with cryo should be avoided due to severe side effects like a high amount of phthisis. Laser assisted techniques are much more safer. Implants may reduce the intraocular pressure effectively, nevertheless one has to struggle with hypotony and scarring around the plates. Some innovative techniques like goniocurettage or aspiration of the trabeculum could be established at certain centers. The ideal glaucoma operation has still to be found.
Similar content being viewed by others
Literatur
Krieglstein GK (2002) Innovative Glaukomchirurgie. Neue Ziele werden gesetzt. Ophthalmologe 99: 73
Dietlein TS (2002) Perspektiven in der Glaukomchirurgie. Ophthalmologe 99: 74–84
Cairns JE (1968) Trabeculectomy: preliminary report of a new method. Am J Ophthalmol 66: 673–679
Fronimopoulos J, Lambrou N, Peekis N, Christakis C (1970) Elliotsche Trepanation mit Skleradeckel. Klin Monatsbl Augenheilkd 156: 1–8
Khalili MA, Diestelhorst M, Krieglstein GK (2000) Langzeituntersuchungen von 700 Trabekulektomien. Klin Monatsbl Augenheilkd 217: 1–8
Ehrnrooth P, Lehto I, Puska P, Laatikainen L (2002) Long-term outcome of trabeculectomy in terms of intraocular pressure. Acta Ophthalmol Scand 80: 267–271
Molteno AB, Bosma NJ, Kittelson JN (1999) Otago Glaucoma Surgery Outcome Study: long-term results of trabeculectomy, 1976–1995. Ophthalmology 106: 1742–1750
Singh K, Mehta K, Shaikh Nm et al (2000) Trabeculectomy with intraoperativ Mitomycin C versus 5-Fluoruracil. Prospective randomised clinical trial. Ophthalmology 107: 2305–2309
Wudunn D, Cantor LB, Palanca-Capistrano AM et al (2002) A prospective randomised trial comparing intraoperative 5-Fluouracil vs Mitoymcin C in primary trabeculectomy. Am J Ophthalmol 134: 521–528
Wilkins M, Indar A, Wormald R (2004) Intra-operative Mitomycin C for glaucoma surgery. Cochrane Review Abstracts, http://www.cochrane.org
Beckers HJ, Kinders KC, Webers CA (2003) Five-year results of trabeculectomy with mitomycin. Graefe’s Arch Clin Exp Ophthalmol 241: 106–110
Marquardt D, Lieb WE, Grehn F (2004) Intensified postoperative care versus conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies. Graefe’s Arch Clin Exp Ophthalmol 242: 106–113
Jampel HD, Quigley HA, Kerrigan-Baumrind LA et al (2001) Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol 119: 1001–1008
Hales AM, Chamberlain CG, McAvoy JW (1995) Cataract induction in lens cultures with transforming growth factor beta. Invest Ophthalmol Vis Sci 36: 1709–1713
Edmunds B, Thompson JR, Salmon JF, Wormald RP (2002) The National Survey of Trabeculectomy. III. Early and late complications. Eye 16: 297–303
Vesti E (1993) Development of cataract after trabeculectomy. Acta Ophthalmol (Copenh) 71: 777–781
The AGIS Investigators (2001) The Advanced Glaucoma Intervention Study (AGIS) 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol 119: 1771–1779
Chen TC, Wilensky JT, Viana MAG (1997) Long-term follow-up of initially successful trabeculectomy. Ophthalmology 104: 1120–1125
Stegmann R, Pienaar A, Miller D (1999) Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 25: 316–322
Mermoud A, Schnyder CC (2000) Nonpenetrating filtering surgery in glaucoma. Curr Opin Ophthalmol 11: 151–157
Schwenn O, Dick B, Pfeiffer N (1998) Trabekulotomie, tiefe Sklerektomie und Viskokanalostomie. Ophthalmologe 95: 835–843
Kobayashi H, Kobayashi K, Okinami S (2003) A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. Graefe’s Arch Clin Exp Ophthalmol 241: 359–366
Jonescu-Cuypers CP, Jacobi PC, Konen W, Krieglstein GK (2001) Primary viscocanalostomy versus trabeculotomy in white patients with open-angle glaucoma. Ophthalmology 108: 254–258
Lüke C, Dietlein TS, Jakobi PC et al (2002) A prospective randomised trial of viscocanalostomy versus trabeculectomy in open-angle glaucoma: a 1-year follow-up study. J Glaucoma 11: 294–299
O’Brart DPS, Rowlands E, Islam N, Noury AMS (2002) A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 86: 748–754
Sanchez E, Schnyder CC, Sickenberg M et al (1997) Deep sclerectomy: results with and without collagen implant. Int Ophthalmol 20: 157–162
Karlen ME, Sanchez E, Schnyder CC et al (1999) Deep sclerectomy with collagen implant: medium term results. Br J Ophthalmol 83: 6–11
Shaarawy T, Karlen M, Schnyder C et al (2001) Five-year results of deep sclerectomy with collagen implant. J Cataract Refract Surg 27: 1770–1778
Shaarawy T, Mansouri K, Schnyder C et al (2004) Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 30: 1225–1231
El Sayyad F, Helal M, El-Kholify H et al (2000) Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology 107: 1671–1674
Kozobolis VP, Christodoulakis EV, Tzanakis N et al (2002) Primary deep sclerectomy versus primary deepsclerectomy with the use of Mitomycin C in primary open-angle glaucoma. J Glaucoma 11: 287–293
Shaarawy T, Flammer J, Smits G, Mermoud A (2004) Low first post-operative day intraocular pressure as a positive prognostic indicator in deep sclerectomy. Br J Ophthalmol 88: 658–661
American Academy of Ophthalmology (2001) Nonpenetrating glaucoma surgery. Ophthalmology 108: 416–421
Dietlein TS, Krieglstein GK (2003) Contra: Non-penetrating surgery and filtration? Graefe’s Arch Clin Exp Ophthalmol 241: 703–704
Shaarawy T, Flammer J (2003) Pro: Non-penetrating glaucoma surgery — a fair chance. Graefe’s Arch Clin Exp Ophthalmol 241: 699–702
Lachkar Y, Hamard P (2002) Nonpenetrating filtering surgery. Curr Opin Ophthalmol 13: 110–115
Strutton DR, Walt JG (2004) Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma 13: 221–226
The AGIS Investigators (2000) The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429–440
Thiel HJ, Denk PO, Knorr M (2000) Sind filtrierende Eingriffe bei Glaukompatienten mit ausgedehnten Gesichtsfeldausfällen mit einem größeren funktionellen Risiko verbunden? Ophthalmologe 97: 336–341
Damji KF, Shah KC, Rock WJ et al (1999) Selective laser trabe-culoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol 83: 718–722
Kramer TR, Noecker RJ (2001) Comparison of the morphologic changes after selective laser trabeculoplasty and argon trabeculoplasty in human eye bank eyes. Ophthalmology 108: 773–780
Latina MA, Tumbocom JAJ (2002) Selective laser trabeculoplasty: a new treatment option for open angle glaucoma. Curr Opin Ophthalmol 13: 94–96
Odberg T, Sandvik L (1999) The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand 77: 176–181
AGIS Investigators(1998) The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Ophthalmology 105: 1146–1164
Dietlein TS, Jacobi PC, Lüke C, Krieglstein GK (2000) Morphological variability of the trabecular meshwork in glaucoma patients: implications for non-perforating surgery. Br J Ophthalmol 84: 1354–1359
Bietti GB (1947) Applicazioni di neve carbonica sulla regione del corpo ciliare come mezzo per ottenere un abbassamento del eono oculare. Atti Soc Oftalmol Ital 9: 64–72
Pham-Duy T (1989) Zyklokryotherapie beim chronischen Glaukom. Fortschr Ophthalmol 86: 214–220
Benson MT, Nelson ME (1990) Cyclocryotherapy: a review of cases over a 10-year period. Br J Ophthalmol 74: 103–105
Pastor SA, Singh K, Lee DA et al (2001) Cyclophotocoagulation. A report by the American Academy of Ophthalmology. Ophthalmology 108: 2130–2138
Uram M (1995) Endoscopic cyclophotocoagulation in glaucoma management. Curr Opin Ophthalmol 6: 19–29
Lin S (2002) Endoscopic cyclophotocoagulation. Br J Ophthalmol 86: 1434–1438
Gandolfi S, Traverso CF, Bron A et al (2002) Short-term results of a miniature draining implant for glaucoma in combined surgery with phacoemulsification. Acta Ophthalmol Scand [Suppl] 236: 66
Lim KS, Allan BDS, Lloyd AW, Muir A, Khaw PT (1998) Glaucoma drainage devices; past, present, and future. Br J Ophthalmol 82: 1083–1089
Hille K, Hille A, Ruprecht KW (2002) Drainagesysteme in der Glaukomchirurgie. Ophthalmologe 99: 902–916
Topouzis F, Yu F, Coleman AL (1998) Factors associated with elevated rates of adverse outcomes after cyclodestructive procedures versus drainage device procedures. Ophthalmology 105: 2276–2281
Wilson MR, Mendis U, Paliwal A, Haynatzka V (2003) Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Am J Ophthalmol 136: 464–470
Jacobi PC, Dietlein TS, Krieglstein GK (1997) Technique of gonio-curettage: a potential treatment for advanced chronic open angle glaucoma. Br J Ophthalmol 81: 302–307
Jacobi PC, Dietlein TS, Krieglstein GK (1998) Bimanual trabecular aspiration in pseudoexfoliation glaucoma: an alternative in nonfiltrating glaucoma surgery. Ophthalmology 105: 886–894
Joussen AM, Walter P, Jonescu-Cuypers CP et al (2003) Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol 87: 1094–1102
Funk J (2004) Laser-Trabekel-Ablation — Operationstechnik, Nutzen vs. Risiken, Perspektiven. Abstract Book der Fortschritte der Ophthalmologie, 22
Burk R, Specht H, Walker R (2002) Sondenentwicklung für die Excimer-Laserkonalostomie. Ophthalmologe 99 [Suppl] 1: 98
Rifkind AW (2002) Update: scierai implants lower IOP at 12 months. Ocular Surgery News, September, 52–53
Dan JA, Honavar SG, Belyea DA et al (2002) Enzymatic sclerostomy. Pilot human study. Arch Ophthalmol 120: 548–553
Spiegel D, Kobuch K, Hill RA, Gross RL (2001) Implantat in den Schlemm-Kanal. Ophthalmologe 98: 94–96
Siriwardena D, Khaw PT, King AJ, Donaldson ML, Overton BM, Migdal C, Cordeiro MF (2002) Human antitransforming growth factor beta (2) monoclonal antibody — a new modulator of wound healing in trabeculectomy. A randomised placebo controlled clinical study. Ophthalmology 109: 427–431
Wimmer I, Grehn F (2002) Steuerung der Wundheilung nach Glaukomchirurgie. Ophthalmologe 99: 678–682
Mietz H, Krieglstein GK (2001) Suramin to enhance glaucoma filtering procedures: a clinical comparison with mitomycin. Ophthalmic Surg Lasers 32: 358–369
Krieglstein GK (1999) Glaucoma. Curr Opin Ophthalmol 10: 81
Khaw PT, Wells AP, Lim KS (2002) Surgery for glaucoma in the 21st century. Br J Ophthalmol 86: 710–711
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Faschinger, C. Ist alles Neue immer besser?. Spektrum Augenheilkd 18, 254–260 (2004). https://doi.org/10.1007/BF03163181
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03163181